Colorectal liver metastases (CRLM) have heterogenous histopathological and immunohistochemical phenotypes, which are associated with variable responses to treatment and outcomes. However, this information is usually only available after resection, and therefore of limited value in treatment planning. Improved techniques for in vivo disease assessment, which can characterise the variable tumour biology, would support further personalization of management strategies. Advanced imaging of CRLM including multiparametric MRI and functional imaging techniques have the potential to provide clinically-actionable phenotypic characterisation. This includes assessment of the tumour-liver interface, internal tumour components and treatment response. Adv...
Les métastases hépatiques du cancer colorectal (MHCR) sont fréquentes et sont associées à une mortal...
J Magn Reson Imaging. 2010 Jan;31(1):19-31. Performance of imaging modalities in diagnosis of liver...
Colorectal cancer (CRC) is one of the most common forms of cancer with annually, 1.36 million new pa...
Colorectal liver metastases (CRLM) have heterogenous histopathological and immunohistochemical pheno...
Colorectal cancer is one of the few malignant tumors in which synchronous or metachronous liver meta...
Background: The assessment of colorectal liver metastases (CRLM) after treatment with chemotherapy i...
Computed tomography (CT), magnetic resonance imaging (MRI), and 18-fluorideoxyglucose positron emiss...
none11noBACKGROUND: The aim of the PROMETEO-01 Study was to define the diagnostic accuracy of ima...
Purpose: We aimed to assess the efficacy of radiomic features extracted by computed tomography (CT) ...
Background: The assessment of colorectal liver metastases (CRLM) after treatment with chemotherapy i...
Liver metastases (mts) from colorectal cancer (CRC) can have different responses to chemotherapy in ...
Oligometastatic colorectal cancer represents an intermediate disease state potentially treatable wit...
(1) Background: colorectal cancer (CRC) is one of the deadliest causes of death by cancer worldwide....
PURPOSE: To use a novel segmentation methodology based on dynamic contrast-enhanced magnetic resonan...
Background: The aim of the study was to define the specific diagnostic accuracy of different imaging...
Les métastases hépatiques du cancer colorectal (MHCR) sont fréquentes et sont associées à une mortal...
J Magn Reson Imaging. 2010 Jan;31(1):19-31. Performance of imaging modalities in diagnosis of liver...
Colorectal cancer (CRC) is one of the most common forms of cancer with annually, 1.36 million new pa...
Colorectal liver metastases (CRLM) have heterogenous histopathological and immunohistochemical pheno...
Colorectal cancer is one of the few malignant tumors in which synchronous or metachronous liver meta...
Background: The assessment of colorectal liver metastases (CRLM) after treatment with chemotherapy i...
Computed tomography (CT), magnetic resonance imaging (MRI), and 18-fluorideoxyglucose positron emiss...
none11noBACKGROUND: The aim of the PROMETEO-01 Study was to define the diagnostic accuracy of ima...
Purpose: We aimed to assess the efficacy of radiomic features extracted by computed tomography (CT) ...
Background: The assessment of colorectal liver metastases (CRLM) after treatment with chemotherapy i...
Liver metastases (mts) from colorectal cancer (CRC) can have different responses to chemotherapy in ...
Oligometastatic colorectal cancer represents an intermediate disease state potentially treatable wit...
(1) Background: colorectal cancer (CRC) is one of the deadliest causes of death by cancer worldwide....
PURPOSE: To use a novel segmentation methodology based on dynamic contrast-enhanced magnetic resonan...
Background: The aim of the study was to define the specific diagnostic accuracy of different imaging...
Les métastases hépatiques du cancer colorectal (MHCR) sont fréquentes et sont associées à une mortal...
J Magn Reson Imaging. 2010 Jan;31(1):19-31. Performance of imaging modalities in diagnosis of liver...
Colorectal cancer (CRC) is one of the most common forms of cancer with annually, 1.36 million new pa...